Toxin-Antidote Genetic System for High-Yield Recombinant Protein Secretion

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for protein secretion in E. coli face limitations such as low yields, size constraints, cytotoxic effects, and complex regulation, particularly for recombinant proteins that are difficult to express or prone to aggregation, necessitating the development of a more efficient and modular secretion system.

Innovation Solution

A genetic system utilizing a solid substrate with a nucleic acid molecule encoding a recombinant amino acid linked to a specific regulatory sequence, induced by an external stimulus like peroxide or autoinducer, allowing for high-efficiency over-expression and secretion of proteins without redox mediators, using a 'burst release' mechanism.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If traditional secretion tags (secA, YebF, OsmY, OmpA) are used for protein secretion in E. coli, then protein secretion is enabled, but protein yields are low and protein size is limited

Engineering Contradiction:
Improveprotein yieldVSAvoidprotein size limitation
Core Design Contradiction:
Quantity of substanceVSAdaptability or versatility

Solution Approach 1:

The invention extracts and removes the limiting factors of traditional secretion systems by eliminating the need for secretion tags entirely. Instead of using conventional tag-based approaches (secA, YebF, OsmY, OmpA) that restrict protein size and yield, the patent employs a toxin-antidote mechanism where the toxin is neutralized by the antidote, allowing unrestricted protein secretion with high yields and no size limitations.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention changes the fundamental parameter of secretion mechanism from tag-dependent to toxin-antidote dependent. By transitioning from conventional secretion tags to a system based on toxin neutralization, the patent achieves dramatic improvements in protein yield and eliminates protein size constraints, fundamentally altering how secretion is accomplished in E. coli.

Inventive Principle:
Principle #35Parameter changes

2Quantity of substance

If permeabilization-inducing mechanisms (hemolysin, curli system, kil switch) are used for protein secretion, then secretion is achieved, but cytotoxic side effects occur and regulation is complex

Engineering Contradiction:
Improveprotein secretion efficiencyVSAvoidcytotoxic side effects
Core Design Contradiction:
Quantity of substanceVSObject-affected harmful factors

Solution Approach 1:

The invention converts the harmful toxin into a beneficial tool for controlling secretion. The toxin, which would normally cause cytotoxic effects, is used in a controlled manner where its activity is neutralized by the antidote only when and where needed. This allows efficient protein secretion while eliminating harmful cytotoxic side effects, as the toxin-antidote system provides precise spatial and temporal control.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

The antidote acts as an intermediary that neutralizes the toxin's harmful effects while allowing the secretion mechanism to function. By introducing this mediating element, the system achieves efficient protein secretion without the cytotoxic side effects that would otherwise result from toxin activity, providing a controlled and safe secretion process.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Quantity of substance

If heterologous proteins are fused to secretion tags for extracellular secretion, then secretion is enabled, but the system becomes complex and optimization of secretion machinery is difficult

Engineering Contradiction:
Improvesecretion capabilityVSAvoidsecretion system complexity
Core Design Contradiction:
Quantity of substanceVSDevice complexity

Solution Approach 1:

The invention extracts and eliminates the complexity of secretion tags and fusion proteins from the system. By removing the need for heterologous protein fusions and conventional secretion tags, the patent achieves a streamlined, tag-free secretion mechanism that is far simpler to implement and optimize, while maintaining high secretion capability through the toxin-antidote approach.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

Instead of adding secretion tags to enable secretion, the invention inverts the approach by using a toxin-antidote system where secretion is enabled through toxin neutralization rather than tag-mediated transport. This inversion simplifies the overall system by eliminating the need for complex tag sequences and fusion proteins, making the secretion machinery easier to optimize.

Inventive Principle:
Principle #13The other way round (Inversion)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This system enables high-yield, size-unrestricted secretion of recombinant proteins without cytotoxic effects, optimizing protein expression and release through a simple, modular mechanism that bypasses traditional secretion tag limitations.

Implementation Method 1

induced by an external stimulus like peroxide or autoinducer

Methodology Applied
Scientific EffectRedox reactions: Redox Reactions

Implementation Method 2

regulatory sequence specific for association with the inducer

Methodology Applied
Scientific EffectGene expression induction: Enzyme

Data Source

PatentUS20230038480A1System for produciton of high yield of recombinant proteins
Publication Date: 2023.02.09 UNIV OF MARYLAND
  • US20230038480A1 patent drawing
  • US20230038480A1 patent drawing
  • US20230038480A1 patent drawing

AI summary

The presently disclosure relates to a system and method for bioelectronic communications. In certain embodiments the system comprises a bacterial cell or cells that comprise a genetic system for high-efficiency over-expression and secretion of recombinant proteins in bacteria. In certain embodiments, the system and method operate in a “pump-then-burst release” fashion to rapidly achieve high yields extracellularly. In certain embodiments, the system and method include quorum sensing-derived regulation, which may enable auto-induction of a protein's expression and secretion.